Page results
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
CAMLIS is the Royal London Hospital for Integrated Medicine (RLHIM) Complementary and Alternative Medicine Information and Library Service and is situated on the ground floor of the hospital.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH has declared a climate and health emergency, and has published a 10-point climate action plan to reach net zero carbon dioxide emissions by 2031.
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Trial of T-cell therapy for lung cancer begins at UCLH
File results
-
FOI/2021/0442 - Cataract surgery
-
FOI/2021/0445 - Fibreoptic endoscopic evaluation of swallowing
-
FOI/2021/0447 - IT solutions used at the Trust
-
FOI/2021/0449 - Treatment of spasticity
-
FOI/2021/0451 - Vaccinated/ unvaccinated patients
-
FOI/2021/0453 - Private security company providing security officers
-
FOI/2021/0457 - International staff
-
FOI/2021/0458 - Breathing filters used in mechanical ventilators for (COVID-19) patients
-
FOI/2021/0463 - Staff accommodation
-
FOI/2021/0466 - Patient wait of more than 52 weeks for elective treatment